7. panická porucha

Praško, J., Pašková, B, Prašková, H., Kosová, J., Šípek, J.: Agorafobie a její léčba:
příručka pro klinickou praxe. Psychiatrické centrum Praha, 1998: 44s
Praško, J., Prašková, H.: Jak zvládat paniku a strach cestovat. Grada, Praha 1999:
Priest RG, Gimbrett R, Roberts M, Steinert J. Reversible and selective inhibitors of
monoamine oxidase A in mental and other disorders. Acta Psychiatrica Scandinavica
Supplement 1995; 386: 40-43
Pyke, R.E., Greenberg, H.S.: Double-blind comparison of alprazolam and adinazolam
for panic and phobic disorders. J. Clin. Psychopharmacol. 1989; 9: 15-21.
Raboch, J., Praško, J., Seifertová, D.: Panické stavy II.díl. Psychiatrická společnost
ČLS JEP, Praha 1999: 56s.
Raboch, J., Seifertová, D., Praško, J.: Panické stavy. Psychiatrická společnost ČLS
JEP, Praha 1998: 54 sRavaris et al. 1991Rickels et al. (1993)¨
Ribeiro L, Busnello JV, Kauer-Sant´Anna M et al. Mirtazapine versus fluoxetine in
the treatment of panic disorder. Braz J Med Biol Res 2001; 34: 1303-1307.
Rickels K, Schweitzer E, Weiss S et al. Maintenance drug treatment for panic
disorder, II: short- and long-term outcome after drug taper. Arch. Gen. Psychiatry.
1993: 50: 61-68.
Rizley, R., Kahn, R.J., McNair, D.M. et al. A comparison of alprazolam and
imipramine in the treatment of agoraphobia and panic disorder. Psychopharmacol.
Bull. 1986; 22: 167-172.
Robinson, D.S., Shrotriya, R.C., Alms, D.R. et al. Treatment of panic disorder:
nonbenzodiazepine anxiolytics, including buspirone. Psychopharmacol. Bull. 1989;
25: 21-26.
Rosenberg, R.: Treatment of panic disorder with tricyclic and MAOIs. In: D.Nutt, J.
Ballenger a J.P. Lepine (eds.): Panic disorder: clinical diagnosis, management and
mechanisms. Dunitz, London. 1999; 125-144.
Roy-Byrne, P.P. a Cowley, D.S.:Course and outcome in panic disorder. A review of
recent follow-up studies. Anxiety 1995; 1: 151-160
Uhlenhuth, E.H., Matuzas, W., Glass, R.M. et al. Response of panic disorder to fixed
doses of alprazolam or imipramine. J. Affect. Disord. 1989; 17: 261-270
Wade AG, Lepola U, Koponen HJ, Pedersen V, Pedersen T. The effect of citalopram
in panic disorder. Br J Psychiatry 1997; 170: 549-553
Wiborg, I.M. a Dahl, A.A.: Does brief dynamic psychotherapy reduce the relapse rate
of panic disorder? Arch. Gen. Psychiatry 1996: 53: 689-694
Sartorius, N., Uestuen, B., Costa de Silva, J.A. et al. An international study of
psychological problems in primary cary: preliminary report from the World Health
Organization Collaborative Project on Psychlogical Probléme in General Health Care.
Archives of General Psychiatry 1993: 50: 819-824
Schneier, F.R., Liebowith, M.R., Davis, S.O. et al. Fluoxetin in panic disorder. J.
Clin. Psychopharmacol. 1990, 10: 119-121.
Schweitzer, E., Pohl, R., Balon, R. et al. Lorazepam v. alprazolam in the treatment of
panic disorder. Pharmacopsychiatry 1990; 23: 90-93
45